Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

Mark Federici on LinkedIn: Fierce Biotech Names Proxygen a “Fierce

Georg Winter (@georg_e_winter) / X

Introducing Fierce Biotech's 2023 Fierce 15

Fierce Biotech on LinkedIn: Treading where Roche and Sanofi failed

Fierce Biotech on LinkedIn: The Future of Biotech

Proxygen LinkedIn

Bernd Boidol, Autor bei Proxygen

Georg Winter (@georg_e_winter) / X

Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

Chris Jenkins على LinkedIn: #genetherapy #community

Proxygen LinkedIn

Jacob Perrett on LinkedIn: What does July's biotech funding reveal